Our previous data showed that SHCBP1 knockdown led to early M-phase entry by downregulating WEE1 expression and subsequently reducing CDK1 phosphorylation at Tyr15, resulting in the abrogation of the G2–M checkpoint in tumour cells (Fig. 4). The gene discussed is WEE1; the disease is neoplasm.